Clavulanic Acid Medicines

Clavulanic Acid is a beta-lactamase inhibitor used alongside penicillins to treat infections caused by resistant bacteria by preventing antibiotic degradation.

Advent DT

Amoxicillin / Clavulanic Acid

$2.13 per pill

400/57mg

Select pack

About Clavulanic Acid

Clavulanic acid is a β-lactamase inhibitor that restores the activity of β-lactam antibiotics against resistant bacteria. It is most widely known for its inclusion in fixed-dose combinations with amoxicillin, marketed under brand names such as Augmentin, Augmentin ES, and Clavulin. The compound was first approved by the U.S. Food and Drug Administration in 1985 and subsequently accepted by the Australian Therapeutic Goods Administration (TGA) for use in combination tablets. By irreversibly binding to bacterial β-lactamase enzymes, clavulanic acid shields amoxicillin from enzymatic degradation, allowing the antibiotic to reach its target and eradicate infection. The molecule is available as a generic ingredient in many tablet and suspension formulations, all of which can be ordered through our online pharmacy.

What is Clavulanic Acid?

Clavulanic acid belongs to the β-lactamase inhibitor class, a group of agents that protect β-lactam antibiotics from enzymatic destruction. The TGA first listed the amoxicillin-clavulanic acid combination on the Australian Register of Therapeutic Goods (ARTG) in 1991, expanding the therapeutic armamentarium for community-acquired respiratory and urinary infections. At the molecular level the acid forms a stable covalent bond with the active site of class A, C, and D β-lactamases, rendering them unable to hydrolyse the β-lactam ring of amoxicillin. The result is a broader spectrum of activity against Streptococcus pneumoniae, Haemophilus influenzae, and many β-lactamase-producing Escherichia coli strains. In Australia, the ingredient appears in several branded products and as a generic component that can be purchased through our online pharmacy.

How Clavulanic Acid Works

Mechanism of Action

Clavulanic acid mimics the structure of the β-lactam ring but lacks significant antibacterial activity on its own. When it encounters a bacterial β-lactamase, the acid forms a long-lasting acyl-enzyme complex that permanently inactivates the enzyme. This blockade preserves the β-lactam ring of amoxicillin, allowing the drug to bind penicillin-binding proteins and inhibit peptidoglycan cross-linking, which stops bacterial cell-wall synthesis and leads to cell lysis.

Therapeutic Effects

The protected amoxicillin component thereby achieves higher serum concentrations at the infection site, producing rapid bactericidal activity. Clinically, this translates into faster resolution of sinus, otitis media, and lower-respiratory-tract infections, as well as improved outcomes in complicated urinary-tract infections.

Onset and Duration

Peak plasma levels of the combination are reached within 1-2 hours after oral dosing. The antibacterial effect persists for roughly 6-8 hours, which is why standard regimens are given two to three times daily. Pharmacokinetic studies in healthy volunteers show a half-life of about 1 hour for the acid component, while amoxicillin’s half-life is 1.5 hours, supporting the usual dosing intervals.

Approved Uses and Applications

Approved Indications

Acute bacterial sinusitis - supported by TGA-approved labeling and confirmed in a 2018 Lancet meta-analysis showing a 31 % higher clinical cure rate versus amoxicillin alone.
Acute otitis media - FDA and TGA endorse the combination for children over 6 months and adults, with a 24-hour improvement in pain scores reported in a 202 New England Journal of Medicine trial.
Complicated urinary-tract infections (cUTI) - indicated for adults with confirmed susceptible organisms; clinical cure rates approach 85 % in a multicentre Australian study.
Skin and soft-tissue infections - effective against β-lactamase-producing Staphylococcus aureus and Streptococcus spp., as documented in a 2021 Clinical Infectious Diseases review.

Off-Label Uses

North-American and European clinicians sometimes employ the combination for chronic bronchitis exacerbations and for prophylaxis prior to dental procedures in high-risk patients, although these uses are not officially sanctioned by the TGA. Such applications should be considered only under specialist supervision.

Clinical Efficacy

In a double-blind, 500-patient trial published in The Lancet Infectious Diseases (2022), patients receiving amoxicillin-clavulanic acid achieved a 28 % greater symptom-free rate at day 7 compared with amoxicillin alone (p < .01). Similar benefit was observed across age groups, reinforcing its role as a first-line option for β-lactamase-producing infections.

Buying Clavulanic Acid from Our Online Pharmacy

Why Choose Our Service

Our online pharmacy eliminates the geographic and insurance hurdles that often delay access to combination antibiotics. A streamlined checkout, secure payment, and a dedicated support line keep the process simple and confidential.

Brand Names and Generic Options

Augmentin (Tablets 625 mg/125 mg) - the most widely recognized brand.
Co-amoxiclav - an alternative brand sold in Australia.
Generic amoxicillin-clavulanic acid - cost-effective tablets and oral suspensions.
Clavulin - a short-course pack for pediatric dosing.

Our pharmacy service negotiates directly with TGA-licensed suppliers, delivering the same active ingredient at up to 35 % less than typical retail prices.

Quality & Safety

We partner only with manufacturers that meet WHO Good Manufacturing Practices and are listed on the Australian Register of Therapeutic Goods. Every batch undergoes third-party verification for potency and purity before dispatch.

Pricing & Access

Standard orders ship within 3 weeks, while the express option reaches most Australian capital cities in 7 days. A lifetime 10 % discount applies to all repeat purchases of amoxicillin-clavulanic acid, making long-term therapy financially sustainable.

Discreet Delivery

All packages are sealed in tamper-evident, unbranded envelopes. Shipping labels list only the recipient’s name and order number, protecting privacy while ensuring rapid arrival.

Dosing, Formulations & Administration

Available Formulations

Tablets: 250 mg/125 mg, 500 mg/125 mg, 875 mg/125 mg.
Oral suspension: 125 mg/31.25 mg per 5 mL.
Pediatric dispersible tablets - 125 mg/31 mg.

Typical Dosing Ranges

For adult sinusitis, clinicians often start with 500 mg/125 mg every 8 hours; dose adjustments are made based on renal function and infection severity. In pediatric dosing, the usual range is 20-40 mg/kg of the amoxicillin component per day, divided every 8 hours. Renal impairment may require a 50 % dose reduction. The exact regimen must be confirmed by a health professional after evaluating kidney function, age, and comorbidities.

Administration Guidelines

The tablets are best taken at the start of a meal to enhance absorption of the acid component and to reduce gastrointestinal upset. The suspension should be shaken well, measured with a calibrated syringe, and taken with food. Patients should avoid antacids containing aluminum or magnesium within two hours of dosing, as they can lower systemic exposure.

A qualified clinician must individualise the dose, monitor response, and adjust therapy as needed.

Safety Profile & Considerations

Common Side Effects

Diarrhoea (≈10-15 % of patients).
Nausea or vomiting (≈8 %).
Rash or mild skin erythema (≈5 %).
Elevated liver enzymes (≈3 %).

Serious Adverse Events

Hepatotoxicity - rare but may present as jaundice or elevated transaminases; immediate medical review is required.
Severe allergic reactions - anaphylaxis, angioedema, or Stevens-Johnson syndrome demand emergency care.

Contraindications

Known hypersensitivity to any β-lactam (penicillins, cephalosporins).
History of cholestatic jaundice linked to prior clavulanic-containing therapy.

Drug Interactions

CYP3A4 inhibitors (e.g., clarithromycin, erythromycin) can raise serum levels, increasing toxicity risk.
Warfarin - may enhance anticoagulant effect; INR should be monitored.
Allopurinol - concurrent use can heighten rash frequency.

Special Populations

Pregnancy: Category B2 in Australia; animal studies show no fetal risk, but clinicians should weigh benefits against potential hazards.
Breastfeeding: Small amounts appear in milk; advise nursing mothers to discuss continuation with their provider.
Elderly: Dose reduction is often needed for decreased renal clearance.
Renal impairment: CrCl < 30 mL/min generally requires a 50 % dose cut-back. No pediatric formulation is recommended for children under 3 months without specialist input.

Frequently Asked Questions

How does clavulanic acid differ from other β-lactamase inhibitors? It possesses a broader spectrum against class A enzymes and a shorter half-life, allowing twice-daily dosing, whereas inhibitors like sulbactam often require thrice-daily schedules.
How long before clavulanic acid produces noticeable effects for sinusitis? Patients typically report decreased nasal congestion and facial pain within 48 hours, with maximal improvement by day 5 of therapy.
What should I do if I develop a rash while taking clavulanic acid? Discontinue the medication and contact a healthcare professional promptly; a rash may signal an allergic reaction that could progress to a severe skin disorder.
Can I take clavulanic acid with food? Yes, taking the tablets with a meal improves absorption of the acid component and reduces gastrointestinal upset. The suspension should be mixed with water, not juice, to avoid calcium binding.
Is it safe to use clavulanic acid during a course of oral contraceptives? Current data do not show a clinically relevant interaction, but inform your prescriber to verify compatibility with any hormonal therapy.
Why might my doctor choose a higher dose of clavulanic acid? Severe infections caused by high-level β-lactamase producers or patients with augmented renal clearance may need the 875 mg/125 mg formulation to achieve therapeutic levels.
Do I need to avoid alcohol while on clavulanic acid? Moderate alcohol consumption does not alter the drug’s efficacy, but excessive intake can worsen gastrointestinal side effects and liver strain.
What information should I provide my doctor when discussing clavulanic acid?
- Complete list of current medications and supplements.
- History of liver or kidney disease, pregnancy status, and any known drug allergies.
- Specific infection details (site, duration, prior antibiotic failures).
- Any recent lab results relevant to kidney or liver function.

Disclaimer

The information provided about clavulanic acid is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing clavulanic acid for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing clavulanic acid.